Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer

NCT03366844 is registered in ClinicalTrials.gov with Stephen Shiao as lead sponsor.

NCT NCT03366844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03366844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer
Lead sponsor
Stephen Shiao
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
December 22, 2017
Completion date
December 7, 2030
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer